Zim Laboratories Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹105.27 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.12 per cent from ₹108.66 crore. This corresponds to a year-on-year *(YoY) decline of 3.18 per cent.
Operating Profit
Operating Profit stands at ₹7.19 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 43.87 per cent from ₹12.81 crore. This corresponds to a year-on-year *(YoY) decline of 50.72 per cent.
PBDT
PBDT stands at ₹10.04 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 9.39 per cent from ₹11.08 crore. This corresponds to a year-on-year *(YoY) decline of 25.02 per cent.
Profit Before Tax
Profit Before Tax stands at ₹4.94 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 18.35 per cent from ₹6.05 crore. This corresponds to a year-on-year *(YoY) decline of 39.01 per cent.
Net Profit
Net Profit stands at ₹3.74 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 15.00 per cent from ₹4.40 crore. This represents a 23.36 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Zim Laboratories Ltd Earnings
- YOY
- QOQ
Zim Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Zim Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Zim Laboratories Ltd Financial Reports
Zim Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Zim Laboratories | 0.00% | 1.11% | 15.17% | 43.00% | 36.84% | 9.52% |
| Shree Ganesh Rem | 7.33% | 5.98% | 18.33% | 20.35% | 32.39% | 0.46% |
| Anuh Pharma | -4.10% | -2.83% | -5.83% | 3.90% | -1.26% | -27.88% |
| Kilitch Drugs | -1.17% | 18.95% | 18.14% | 11.55% | 0.59% | -19.21% |
| Jenburkt Pharma | -0.77% | -4.38% | 8.47% | 14.07% | -3.89% | -0.59% |
| Amanta Healthcar | 1.15% | -1.81% | -5.84% | 22.55% | 13.49% | -9.38% |
| Valiant Laborato | 2.01% | -3.78% | 12.73% | 26.97% | 8.71% | -22.20% |
Company Info
Company Information
Chairman & Managing Director : Anwar S Daud
Director (Finance) : Zulfiquar M Kamal
Whole Time Director : Prakash Sapkal
Director (Business Development) : Niraj Dhadiwal
Independent Director : Kavita Loya
Independent Director : Padmakar Joshi
Company Sec. & Compli. Officer : Piyush Nikhadi
Independent Director : Kamlesh Shende
Independent Director : Ashok Bhatia